Device financing reached $934 million during 2015's first quarter, a slight increase over Q4's $902 million. (See Exhibit 1.) Representing 37% of the financing total, follow-on public offerings drove most of the quarter's fundraising with $343 million, a significant increase over Q4's sole $12 million FOPO by implantable orthopedic device and biomaterials company Amedica Corp.[See Deal]
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?